SIS Ventures

Dxcover is a clinical-stage liquid biopsy company based in Glasgow, established in 2016 by David S Palmer, Holly Butler, and Matthew Baker. The firm specializes in developing advanced diagnostics for the early detection of various cancers, focusing on Stage I and Stage II malignancies where timely intervention can significantly improve patient outcomes. Utilizing a combination of infrared spectroscopy and artificial intelligence, Dxcover's technology enables the detection of cancer from a simple blood sample, allowing for same-day diagnosis and patient stratification. This innovative approach aims to enhance treatment options and ultimately improve survival rates and quality of life for patients.

MiAlgae is a microalgae production company that provides microalgal products rich in omega-3 fatty acids, proteins, and antioxidants for livestock feeds. It aims to replace fishmeal in animal food, including aquaculture, by producing nutrients from algae rather than wild catch. The company emphasizes sustainability through circular economy practices and wastewater remediation to lower production costs and reduce environmental impact. Founded in 2016 and based in Edinburgh, United Kingdom, MiAlgae pursues scalable, seafood-free sources of essential nutrients for livestock feeds.

Beta Bugs specializes in insect genetics, developing high-performance Black Soldier Fly breeds for insect farmers. Headquartered at Easter Bush Campus, it collaborates with the Roslin Institute to enhance productivity in the insect protein sector.

Microplate Dx develops innovative diagnostic technology aimed at reducing fatalities caused by drug-resistant infections. The company, spun out from the University of Strathclyde in Glasgow, focuses on creating point-of-care solutions that accurately detect specific infections and enable optimal antibiotic prescribing within an hour.

Dxcover is a clinical-stage liquid biopsy company based in Glasgow, established in 2016 by David S Palmer, Holly Butler, and Matthew Baker. The firm specializes in developing advanced diagnostics for the early detection of various cancers, focusing on Stage I and Stage II malignancies where timely intervention can significantly improve patient outcomes. Utilizing a combination of infrared spectroscopy and artificial intelligence, Dxcover's technology enables the detection of cancer from a simple blood sample, allowing for same-day diagnosis and patient stratification. This innovative approach aims to enhance treatment options and ultimately improve survival rates and quality of life for patients.

MiAlgae is a microalgae production company that provides microalgal products rich in omega-3 fatty acids, proteins, and antioxidants for livestock feeds. It aims to replace fishmeal in animal food, including aquaculture, by producing nutrients from algae rather than wild catch. The company emphasizes sustainability through circular economy practices and wastewater remediation to lower production costs and reduce environmental impact. Founded in 2016 and based in Edinburgh, United Kingdom, MiAlgae pursues scalable, seafood-free sources of essential nutrients for livestock feeds.

Dxcover is a clinical-stage liquid biopsy company based in Glasgow, established in 2016 by David S Palmer, Holly Butler, and Matthew Baker. The firm specializes in developing advanced diagnostics for the early detection of various cancers, focusing on Stage I and Stage II malignancies where timely intervention can significantly improve patient outcomes. Utilizing a combination of infrared spectroscopy and artificial intelligence, Dxcover's technology enables the detection of cancer from a simple blood sample, allowing for same-day diagnosis and patient stratification. This innovative approach aims to enhance treatment options and ultimately improve survival rates and quality of life for patients.